Forbion related stories
All articles and analysis
- Medical Device Co. PneumRx Inks $33M
PneumRx Inc., a medical device company focused on treatments for lung disease, has raised $33 million in Series C venture funding. European firms Forbion Capital Partners and Endeavour Vision co-led the round, which included investments from Adams Street Partners, Telegraph Hill Partners, Alta Partners, Spray Venture Partners, Silicon Valley Bank and Leader Ventures. PneumRx is based in Mountain View, Calif.
- European Fund Briefs, October
Fund-raising news about Forbion Capital Partners, Octopus Investments, Barclays Private Equity, Verdane Capital Advisors, Montagu and a successor fund to Italy’s Valiance
- VC fund briefs, week of Sept. 13, 2010
VC fund-raising news briefs
- Forbion Capital Closes FCF I Co-Invest Fund and of FCF II; A Total Of €190M Was Raised
Forbion Capital Partners, a Netherlands-based venture capital firm that invests in the life science sector, held the final closings of FCF I Co-Invest Fund and of FCF II. It raised a total of more than €190 million ($240 million). Forbion Capital invests in private companies developing novel drugs, medical devices and diagnostics for high- or even unmet medical needs.
- peHUB Wire: Monday, June 7, 2010
Random Ramblings
- peHUB Wire: Monday, June 7, 2010
Random Ramblings
- Week in deals, May 17, 2010
Summary of tech companies and other startups in North America that raised venture financing in the past week
- Exosome Diagnostics Raises $20 Million
Exosome Diagnostics Inc., a New York-based developer of minimally-invasive molecular diagnostics, has raised $20 million in Series A funding. NGN Capital and Forbion Capital Partners co-led the round.
- peHUB Wire: Wednesday, May 12, 2010
Random Ramblings